IRIS
CHIRONNA, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.308
EU - Europa 2.551
AS - Asia 1.363
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 4
OC - Oceania 4
Totale 13.253
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.276
CN - Cina 749
IT - Italia 627
SE - Svezia 614
SG - Singapore 451
DE - Germania 369
FI - Finlandia 265
UA - Ucraina 225
GB - Regno Unito 168
RU - Federazione Russa 104
FR - Francia 62
VN - Vietnam 60
IN - India 41
CA - Canada 30
BE - Belgio 25
IE - Irlanda 23
HK - Hong Kong 19
IR - Iran 17
LT - Lituania 13
CZ - Repubblica Ceca 12
BR - Brasile 10
NL - Olanda 10
ES - Italia 8
GR - Grecia 8
TR - Turchia 7
AT - Austria 5
PH - Filippine 5
AR - Argentina 4
AU - Australia 3
EU - Europa 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CL - Cile 2
EC - Ecuador 2
EG - Egitto 2
JP - Giappone 2
LV - Lettonia 2
MK - Macedonia 2
MY - Malesia 2
RO - Romania 2
SS - ???statistics.table.value.countryCode.SS??? 2
ZA - Sudafrica 2
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
MM - Myanmar 1
MT - Malta 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
TH - Thailandia 1
Totale 13.253
Salva come PNG Salva come JPEG
Città #
Fairfield 1.186
Chandler 923
Woodbridge 836
Ashburn 686
Jacksonville 562
Houston 549
Seattle 515
Nyköping 494
Cambridge 454
Wilmington 445
Singapore 372
Ann Arbor 349
Roxbury 216
Lawrence 213
New York 178
Bari 173
Nanjing 171
Des Moines 142
Modugno 133
Inglewood 128
Beijing 125
Kansas City 120
Helsinki 113
Princeton 102
Boardman 94
Boydton 74
Dong Ket 58
Hebei 57
San Diego 55
Munich 52
Shenyang 49
Santa Clara 46
Jiaxing 44
Dearborn 41
Nanchang 40
Paris 40
Milan 34
Changsha 30
Tianjin 29
San Mateo 26
Brussels 25
London 24
Los Angeles 23
Toronto 23
Dublin 22
Guangzhou 21
Rome 21
Washington 20
Brooklyn 19
Jinan 18
Falls Church 17
Hong Kong 17
Redwood City 17
Pune 16
Ardabil 14
Leawood 13
Zhengzhou 13
Augusta 12
Brno 11
Chiswick 10
Frankfurt am Main 10
Mumbai 10
Norwalk 9
Shanghai 9
Haikou 8
Hefei 8
Lappeenranta 8
Nürnberg 8
Taizhou 8
Wuhan 8
Kilburn 7
Salerno 7
San Francisco 7
São Paulo 7
Auburn Hills 6
Chicago 6
Indianapolis 6
Kunming 6
Monmouth Junction 6
Bloomington 5
Ningbo 5
Nuremberg 5
Redmond 5
Stockholm 5
Bologna 4
Buffalo 4
Catania 4
Columbia 4
Falkenstein 4
Florence 4
Fuzhou 4
Genoa 4
Hounslow 4
Lanzhou 4
Ottawa 4
Tappahannock 4
Taranto 4
Turi 4
Acton 3
Amsterdam 3
Totale 10.541
Salva come PNG Salva come JPEG
Nome #
Proceedings of the Consensus Day Meeting: Implications for Rotavirus Vaccination in the 2014 Apulian Lifetime Immunization Schedule. Foggia, 17 April 2015 168
A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement 158
Epidemiological dynamics of norovirus GII. 4 variant new orleans 2009 149
Identification of the novel Kawasaki 2014 GII.17 human norovirus strain in Italy, 2015 143
Estimation of the impact of meningococcal serogroup C universal vaccination in Italy and suggestions for the multicomponent serogroup B vaccine introduction 134
High public-health impact in an influenza-b-mismatch season in southern Italy, 2017-2018 130
Case-management protocol for bloody diarrhea as a model to reduce the clinical impact of Shiga toxin-producing Escherichia coli infections. Experience from Southern Italy 124
First Description of Macrolide-Resistant Mycoplasma pneumoniae in Adults with Community-Acquired Pneumonia in Italy 120
Clonal spread of a unique strain of macrolide-resistant mycoplasma pneumoniae within a single family in Italy 116
Outbreak of Salmonella infantis gastroenteritis among people who had eaten at a hash house in southern Italy 113
Resurgence of Pertussis and Emergence of the Ptxp3 Toxin Promoter Allele in South Italy 111
Sentinel hospital-based surveillance for norovirus infection in children with gastroenteritis between 2015 and 2016 in Italy 109
Evaluation of a vaccination strategy by serosurveillance data: The case of varicella 106
Seroprevalence of Dengue Virus, West Nile Virus, Chikungunya Virus, and Zika Virus in International Travelers Attending a Travel and Migration Center in 2015-2017, Southern Italy 106
Towards measles elimination in Italy: Virological surveillance and genotypes trend (2013–2015) 105
Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017 105
Outbreak of Hepatitis A in Italy Associated with Frozen Redcurrants Imported from Poland: A Case Study 103
null 102
Norovirus GII.17 as Major Epidemic Strain in Italy, Winter 2015-16 101
Key role of sequencing to trace hepatitis a viruses circulating in Italy during a large multi-country European foodborne outbreak in 2013 97
Analysis of GII.P7 and GII.6 noroviruses circulating in Italy during 2011-2016 reveals a replacement of lineages and complex recombination history 97
null 94
Community-wide outbreak of haemolytic uraemic syndrome associated with Shiga toxin 2-producing Escherichia coli O26:H11 in southern Italy, summer 2013 92
Molecular characterization of two rare human G8P[14] rotavirus strains, detected in Italy in 2012 90
Cocirculation of Hajj and non-Hajj strains among serogroup W meningococci in Italy, 2000 to 2016 87
2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children 86
Prevalence of human papillomavirus infection in a clinic sample of transsexuals in Italy 85
Persistence of immunity 18-19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy. 85
Acute Delta Hepatitis in Italy spanning three decades (1991–2019): Evidence for the effectiveness of the hepatitis B vaccination campaign 84
Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy 83
Risk of zoster in patients on immunosuppressant therapy: Evaluation of current data 82
null 81
null 80
Epidemiological aspects of seasonal and pandemic influenza in recent years and emerging viruses 78
Evaluation of measles and rubella integrated surveillance system in Apulia region, Italy, 3 years after its introduction 78
null 77
Surveillance of hepatitis A virus in urban sewages and comparison with cases notified in the course of an outbreak, Italy 2013 77
Emerging high-risk ST101 and ST307 carbapenem-resistant Klebsiella pneumoniae clones from bloodstream infections in Southern Italy 77
null 75
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza 74
Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season 74
Measles in Italy: Co-circulation of B3 variants during 2014 72
null 71
null 71
null 71
First detection of autochthonous extensively drug-resistant NDM-1 Pseudomonas aeruginosa ST235 from a patient with bloodstream infection in Italy, October 2019 71
null 69
Seroprevalence of Dengue Virus (DV), West Nile virus (WNV), Chikungunya virus (CHIKV) and Zika virus (ZV) in Italian international travelers 69
null 68
Astrovirus VA1 in patients with acute gastroenteritis 68
2015/16 SEASONAL VACCINE EFFECTIVENESS AGAINST HOSPITALISATION WITH INFLUENZA A(H1N1)PDM09 AND B AMONG ELDERLY PEOPLE IN EUROPE: RESULTS FROM THE I-MOVE+ PROJECT 67
null 67
null 66
null 66
null 66
People living with undiagnosed HIV infection and a low CD4 count: Estimates from surveillance data, Italy, 2012 to 2014 64
null 64
Meropenem/vaborbactam activity in vitro: a new option for Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae treatment 64
Effectiveness of the 13-valent pneumococcal conjugate vaccine against adult pneumonia in Italy: A case-control study in a 2-year prospective cohort 63
[Regional HIV Surveillance in Italy: a starting point for the future national system] 63
null 61
null 61
Recurrence of COVID-19 after recovery: a case report from Italy 61
null 60
null 60
null 60
Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006-2014 60
Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization dueto influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017 – 2018 season 60
null 59
null 59
Twenty years of surveillance of Invasive Meningococcal Diseases in Puglia, Italy 59
Prevalence and antibiotic resistance of Pseudomonas aeruginosa in water samples in central Italy and molecular characterization of oprD in imipenem resistant isolates 59
Epidemiology of Shiga Toxin-Producing Escherichia coli Infections in Southern Italy after Implementation of Symptom-Based Surveillance of Bloody Diarrhea in the Pediatric Population 59
A Cluster of Cryptic Plasmodium falciparum Malaria in African Migrants in Southern Italy, October 2017 59
COVID-19 hospital outbreaks: Protecting healthcare workers to protect frail patients. An Italian observational cohort study 59
Symptomatic SARS-CoV-2 Reinfection in a Healthy Healthcare Worker in Italy Confirmed by Whole-Genome Sequencing 59
null 58
null 58
null 58
ROTAVIRUS GENOTYPES IN SEWAGE TREATMENT PLANTS AND IN CHILDREN HOSPITALIZED WITH ACUTE DIARRHEA IN ITALY, 2010 – 2011 58
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies 58
null 58
SARS-CoV-2 Infection in Children in Southern Italy: A Descriptive Case Series 57
null 57
null 56
null 56
null 56
63 days detection of SARS-CoV-2 RNA from a recovered patient in Southern Italy: A Case Report 56
Measles outbreak in Apulia, southern Italy 55
null 54
null 54
null 54
The Challenge of Using an Antigen Test as a Screening Tool for SARS-CoV-2 Infection in an Emergency Department: Experience of a Tertiary Care Hospital in Southern Italy 54
null 53
Towards the 13-valent pneumococcal conjugate universal vaccination. Effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013 52
null 52
Severe COVID-19 by SARS-CoV-2 lineage B.1.1.7 in vaccinated solid-organ transplant recipients: New preventive strategies needed to protect immunocompromised patients 52
Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe – Results from the DRIVE EU study platform 52
null 51
null 51
Totale 7.691
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.803
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.523 0 0 0 0 0 172 309 277 328 151 217 69
2020/20212.636 174 96 240 277 446 196 222 130 192 248 276 139
2021/20221.467 60 94 23 90 85 128 70 84 117 111 287 318
2022/20232.583 357 316 172 177 369 239 47 295 476 26 55 54
2023/20241.328 64 388 51 126 146 291 34 42 25 31 26 104
2024/20251.310 146 74 408 302 108 272 0 0 0 0 0 0
Totale 14.226